These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 33351079)

  • 1. Anti-Müllerian Hormone Levels in Adolescence in Relation to Long-term Follow-up for Presence of Polycystic Ovary Syndrome.
    Caanen MR; Peters HE; van de Ven PM; Jüttner AMFM; Laven JSE; van Hooff MHA; Lambalk CB
    J Clin Endocrinol Metab; 2021 Mar; 106(3):e1084-e1095. PubMed ID: 33351079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do the Anti-Müllerian Hormone Levels of Adolescents with Polycystic Ovary Syndrome, Those Who Are at Risk for Developing Polycystic Ovary Syndrome, and Those Who Exhibit Isolated Oligomenorrhea Differ from Those of Adolescents with Normal Menstrual Cycles?
    Savas-Erdeve S; Keskin M; Sagsak E; Cenesiz F; Cetinkaya S; Aycan Z
    Horm Res Paediatr; 2016; 85(6):406-11. PubMed ID: 27173790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Müllerian hormone: correlation with testosterone and oligo- or amenorrhoea in female adolescence in a population-based cohort study.
    Pinola P; Morin-Papunen LC; Bloigu A; Puukka K; Ruokonen A; Järvelin MR; Franks S; Tapanainen JS; Lashen H
    Hum Reprod; 2014 Oct; 29(10):2317-25. PubMed ID: 25056088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
    Dewailly D; Alebić MŠ; Duhamel A; Stojanović N
    Hum Reprod; 2014 Nov; 29(11):2536-43. PubMed ID: 25267785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the presence of polycystic ovary syndrome-related features on anti-Mullerian hormone and androstenedione levels in adolescents with or without menstrual irregularity.
    Hanedan N; Ersoy B; Hanedan C; Ozyurt BC; Taneli F
    Arch Gynecol Obstet; 2022 Aug; 306(2):523-531. PubMed ID: 35355114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S; Laven JSE; Duhamel A; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Diagnostic Value of Anti-Müllerian Hormone in Early Post Menarche Adolescent Girls with Polycystic Ovarian Syndrome.
    Kocaay P; Siklar Z; Buyukfirat S; Berberoglu M
    J Pediatr Adolesc Gynecol; 2018 Aug; 31(4):362-366. PubMed ID: 29462707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum anti-mullerian hormone concentrations are elevated in oligomenorrheic girls without evidence of hyperandrogenism.
    Park AS; Lawson MA; Chuan SS; Oberfield SE; Hoeger KM; Witchel SF; Chang RJ
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1786-92. PubMed ID: 20150576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
    Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parallel variations of insulin-like peptide 3 (INSL3) and antimüllerian hormone (AMH) in women with the polycystic ovary syndrome according to menstrual cycle pattern.
    Pelusi C; Fanelli F; Pariali M; Zanotti L; Gambineri A; Pasquali R
    J Clin Endocrinol Metab; 2013 Oct; 98(10):E1575-82. PubMed ID: 23928669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of anti-Mullerian hormone and other correlates in patients with polycystic ovary syndrome.
    Moursi MO; Salem H; Ibrahim AR; Marzouk S; Al-Meraghi S; Al-Ajmi M; Al-Naimi A; Alansari L
    Gynecol Endocrinol; 2023 Aug; 39(1):2247098. PubMed ID: 37573873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between serum anti-Mullerian hormone and clinical parameters in polycystic ovary syndrome.
    Matsuzaki T; Munkhzaya M; Iwasa T; Tungalagsuvd A; Yano K; Mayila Y; Yanagihara R; Tokui T; Kato T; Kuwahara A; Matsui S; Irahara M
    Endocr J; 2017 May; 64(5):531-541. PubMed ID: 28381699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can we use serum Anti-Mullerian hormone to differentiate the diagnosis between polycystic ovary syndrome patients and healthy women with polycystic ovarian morphology and regular menstrual cycles.
    Aydoğmuş H; Kelekçi S; Elmalı F; Aydoğmuş S
    Saudi Med J; 2018 Oct; 39(10):1011-1016. PubMed ID: 30284584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Müllerian Hormone and Ovarian Morphology in Women With Hypothalamic Hypogonadism.
    Alemyar A; van der Kooi ALF; Laven JSE
    J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32170295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
    Parahuleva N; Pehlivanov B; Orbecova M; Uchikova E; Ivancheva H
    Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligo/Amenorrhea Is an Independent Risk Factor Associated With Low Ovarian Response.
    Hu KL; Gan K; Ying Y; Zheng J; Chen R; Xue J; Wu Y; Liu Y; Zhu Y; Xing L; Zhang D
    Front Endocrinol (Lausanne); 2021; 12():612042. PubMed ID: 34177795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D deficiency, insulin resistance, and antimüllerian hormone level: a tale of trio in the expression of polycystic ovary syndrome.
    Chakraborty S; Naskar TK; Basu BR
    F S Sci; 2024 Aug; 5(3):252-264. PubMed ID: 38876205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women.
    Wongwananuruk T; Panichyawat N; Indhavivadhana S; Rattanachaiyanont M; Angsuwathana S; Techatraisak K; Pratumvinit B; Sa-Nga-Areekul N
    Taiwan J Obstet Gynecol; 2018 Aug; 57(4):499-506. PubMed ID: 30122568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Müllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome.
    Somunkiran A; Yavuz T; Yucel O; Ozdemir I
    Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):196-201. PubMed ID: 17335955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.
    Fraissinet A; Robin G; Pigny P; Lefebvre T; Catteau-Jonard S; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1716-1722. PubMed ID: 28854589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.